However, ectopic expression of GLI-1 increased KRAS promoter activity in cancer cells without KRASG12C-inhibitor treatment (Fig. 6A), suggesting that GLI-1 plays a role in enhancing KRAS-promotor activity. The gene discussed is GLI1; the disease is cancer.